Skip to main content

Table 3 Baseline characteristics of the patients

From: Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 – 2016)

Study

Age (year)

Males (%)

HT (%)

Ds (%)

DM (%)

CS (%)

 

C + PPI/C alone

C + PPI/C alone

C + PPI/C alone

C + PPI/C alone

C + PPI/C alone

C + PPI/C alone

Bhurke 2012

61.5/59.6

68.7/76.3

-

-

28.9/26.4

-

Burkard 2012

66.5/63.3

68.8/79.9

72.5/65.0

73.4/75.9

29.6/17.2

24.8/29.8

Chitose 2012

70.3/68.9

71.6/72.2

77.9/79.0

61.9/61.7

35.3/33.7

23.9/26.2

Douglas 2012

71.0/68.0

58.0/65.0

-

-

34.0/29.0

16.0/18.0

Dunn 2013

63.9/62.5

69.3/72.3

49.5/51.5

39.4/41.2

16.5/20.3

23.9/29.6

Goodman 2012

63.0/62.0

72.4/71.2

65.6/65.4

49.8/45.0

25.8/24.7

36.2/35.7

Hsieh 2015

68.4/66.5

63.6/66.4

-

-

-

-

Macaione 2012

63.7/65.8

80.2/87.3

70.2/81.8

53.7/58.2

41.3/49.1

37.2/27.3

Weisz 2015

64.4/63.2

70.1/75.9

83.7/77.8

76.9/73.2

34.8/31.4

22.7/22.6

Zou 2014

66.2/65.7

73.5/73.9

71.3/70.4

60.2/62.3

25.8/23.6

32.2/31.0

Gargiolo 2016

71.2/68.1

72.5/79.2

72.5/71.3

53.8/55.3

23.3/24.8

22.6/24.4

  1. Abbreviations: C Clopidogrel, PPI Proton pump inhibitor, HT Hypertension, Ds Dyslipidemia, DM Diabetes mellitus, CS Current smoker